RNAi With Zilebesiran for Hypertension, Timing of IV Thrombolysis Before Thrombectomy for Stroke, Cardiac Amyloidosis Review, and more
Editor’s Summary by Christopher W. Seymour, MD, MSc, Associate Editor of JAMA, the Journal of the American Medical Association, for the March 5, 2024, issue. (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - March 5, 2024 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Million Hearts Model and CV Events, Eplontersen for ATTRv Amyloidosis Polyneuropathy, Hyperthyroidism Review, and more
Editor’s Summary by Kristin Walter, MD, MS, Senior Editor of JAMA, the Journal of the American Medical Association, for the October 17, 2023, issue. Related Content: Audio Highlights (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - October 17, 2023 Category: General Medicine Authors: JAMA Network Source Type: podcasts
JAMA Cardiology : Tracking Treatment Response in Cardiac Light-Chain Amyloidosis With Native T1 Mapping
Interview with Marianna Fontana, MD, PhD, author of Tracking Treatment Response in Cardiac Light-Chain Amyloidosis With Native T1 Mapping, and Sarah A. M. Cuddy, MB, BCh, BAO, author of Imaging Biomarkers in the Management of Light-Chain Cardiac Amyloidosis. Hosted by James Udelson, MD. Related Content: Tracking Treatment Response in Cardiac Light-Chain Amyloidosis With Native T1 Mapping Imaging Biomarkers in the Management of Light-Chain Cardiac Amyloidosis (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - July 19, 2023 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Probiotics for Care Home Residents, Noninvasive Ventilation and Mortality, Review of Systemic Amyloidosis, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the July 7, 2020 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - July 7, 2020 Category: General Medicine Authors: JAMA Network Source Type: podcasts
How To Implement MRD Testing In Daily Practice
Suzanne Lentzsch, M.D., PhD Associate Professor of Medicine & Director of the Multiple Myeloma and Amyloidosis Service at Columbia University Medical Center. Discusses How To Implement MRD Testing In ...
Author: imedex
Added: 12/31/2018 (Source: Oncology Tube)
Source: Oncology Tube - December 31, 2018 Category: Cancer & Oncology Source Type: podcasts
The potential of anti-amyloid antibodies to treat amyloidosis
Dr Suzanne Lentzsch, MD, PhD, of Columbia University, New York, NY, presents data from the latest clinical trials testing drugs for amyloidosis. Lentzsch reports on an ongoing study that compares the ...
Author: VJHemOnc
Added: 09/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 28, 2018 Category: Cancer & Oncology Source Type: podcasts
If Practitioner Identifies Light-Chain Amyloidosis | Referring to Site Where Trial is Open is a Great Idea
Ray Comenzo, MD, Tufts Medical Center, explains If Practitioner Identifies Light-Chain Amyloidosis | Referring to Site Where Trial is Open is a Great Idea at ASCO 2018
Author: Annual-Meeting
Added: 06/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 20, 2018 Category: Cancer & Oncology Source Type: podcasts
Earlier Diagnosis for Smoldering Multiple Myeloma or Monoclonal Gammopathy of Unknown Significance | At Risk of Progressing to Light-chain Amyloidosis
Ray Comenzo, MD, Tufts Medical Center, explains Earlier Diagnosis for SMM or MGUS | At Risk of Progressing to Light-chain Amyloidosis at ASCO 2018
Author: Annual-Meeting
Added: 06/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 20, 2018 Category: Cancer & Oncology Source Type: podcasts
Treatment outcomes of elderly patients with AL Amyloidosis
Systemic amyloid light-chain (AL) amyloidosis, a disease with improving outcomes using novel therapies, is increasingly recognized in the elderly, but treatment and outcomes have not been systematical...
Author: VJHemOnc
Added: 05/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 4, 2018 Category: Cancer & Oncology Source Type: podcasts
Unmet needs in amyloidosis
A large contributing factor to outcome in amyloidosis is the stage of diagnosis. Here, Giampaolo Merlini, MD, from the University of Pavia, Paiva, Italy, discusses the need to improve outcomes in pati...
Author: VJHemOnc
Added: 05/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 4, 2018 Category: Cancer & Oncology Source Type: podcasts
New antibody treatments for AL amyloidosis
This is an exciting time for the treatment of amyloid light-chain (AL) amyloidosis, with a number of novel therapies on the horizon. In this interview, Giampaolo Merlini, MD, from the University of Pa...
Author: VJHemOnc
Added: 05/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 4, 2018 Category: Cancer & Oncology Source Type: podcasts
Biomarkers of amyloidosis
New insights into amyloid light-chain (AL) amyloidosis have emerged in recent years. Here, Giampaolo Merlini, MD, from the University of Pavia, Paiva, Italy, gives an overview of the mechanisms behind...
Author: VJHemOnc
Added: 05/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 4, 2018 Category: Cancer & Oncology Source Type: podcasts
Final Analysis of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Pts with RR Amyloidosis
Final Analysis of the Phase 1a/b Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with RR Amyloidosis<br /><br />Suzanne Lentzsch, MD, PhD<br />Columbia University Medical Center<br />New York...
Author: InternationalMyelomaFoundation
Added: 01/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 16, 2018 Category: Cancer & Oncology Source Type: podcasts
Major breakthroughs in AL amyloidosis treatment from ASH 2017
Several major breakthroughs in the treatment of amyloid light-chain (AL) amyloidosis were presented at the American Society of Hematology (ASH) 2017 Annual Meeting and Exposition in Atlanta, GA. In th...
Author: VJHemOnc
Added: 01/03/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 3, 2018 Category: Cancer & Oncology Source Type: podcasts
Upcoming amyloidosis clinical trial data to look forward to at ASH 2017
In this interview, recorded at the Myeloma 2017 meeting in Edinburgh, UK, Ashutosh Wechalekar, MBBS, MD, FRCP, FRCPath, DM, from University College London, London, UK, talks to us about the most antic...
Author: VJHemOnc
Added: 11/17/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 17, 2017 Category: Cancer & Oncology Source Type: podcasts
